Moderna Stock Falls Amid Broad Sell-Off Shares of Moderna are down by 7% today as higher Treasury yields put significant pressure on high-growth stocks. There is a broad sell-off in the market, and S&P 500 is down by almost 2%.
Full Answer
When will Moderna stock be a screaming buy?
Apr 01, 2022 · Moderna's stock was trading at $23.61 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MRNA shares have increased by 573.4% and is now trading at $159.00. View which stocks have been most impacted by COVID-19.
Should I buy Moderna?
Feb 14, 2022 · Moderna Stock Drops As Skepticism About Future Vaccine Sales Grows Shares of Moderna gained downside momentum after the FDA postponed a meeting on the authorization of Pfizer / BioNTech vaccine ...
Should I Sell Moderna?
Jan 27, 2022 · The stock price of Moderna, Inc. (NASDAQ: MRNA) fell by over 4% today. This is why it happened. Investors are responding negatively to the company revealing that the antibody levels against the omicron variant fell 6.3 times six months after getting the third dose of its mRNA Covid-19 vaccine.
Is Moderna publicly traded?
Sep 28, 2021 · Moderna Stock Falls Amid Broad Sell-Off. Shares of Moderna are down by 7% today as higher Treasury yields put significant pressure on high-growth stocks. There is a broad sell-off in the market, and S&P 500 is down by almost 2%. Moderna shares underperform as they have gained almost 300% year-to-date so traders are ready to take some profits off the table on …
Is Moderna a buy right now?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Moderna in the last twelve months. There are currently 1 sell rating, 9 h...
How has Moderna's stock price been impacted by COVID-19?
Moderna's stock was trading at $23.61 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since t...
When is Moderna's next earnings date?
Moderna is scheduled to release its next quarterly earnings announcement on Thursday, May 5th 2022. View our earnings forecast for Moderna .
How were Moderna's earnings last quarter?
Moderna, Inc. (NASDAQ:MRNA) issued its earnings results on Thursday, February, 24th. The company reported $11.29 EPS for the quarter, beating the T...
What price target have analysts set for MRNA?
16 brokerages have issued 12 month price targets for Moderna's stock. Their forecasts range from $81.00 to $395.00. On average, they expect Moderna...
Who are Moderna's key executives?
Moderna's management team includes the following people: Stéphane Bancel , Chief Executive Officer & Director Stephen Hoge , President ( Linked...
What is Stéphane Bancel's approval rating as Moderna's CEO?
57 employees have rated Moderna CEO Stéphane Bancel on Glassdoor.com . Stéphane Bancel has an approval rating of 92% among Moderna's employees. Th...
Who are some of Moderna's key competitors?
Some companies that are related to Moderna include Amgen (AMGN) , Gilead Sciences (GILD) , BioNTech (BNTX) , Biogen (BIIB) , Seagen (SGEN) ,...
What other stocks do shareholders of Moderna own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Moderna investors own include NVIDIA (NVDA) , Tesla (TSLA...
The rise and fall of Moderna
Moderna has grown from a small and unknown company to one of the best-known globally. As a result, the company’s MRNA stock price jumped from a low of $11 in 2019 to almost $500 in 2021. Today, the stock is trading at $160, bringing its total market capitalization to about $64 billion.
Moderna pipeline
Another reason why the Moderna stock price has declined is that investors are concerned about the company’s pipeline. A pipeline is the number of vaccines or drugs in various phases of their development.
Is Moderna a good investment?
So, the most common question among investors is whether Moderna is a good investment after its stock crashed by more than 60% from its all-time high.
Is Moderna overvalued or undervalued?
So, the most important question that people ask before they invest in a stock is whether it is overvalued or not. So, is the Moderna stock price overvalued?
Moderna stock price forecast 2022
Analysts are generally optimistic about the MRNA share price. According to Marketbeat, analysts have an average target of $245 for the stock. That price is about 53% above the current level. The most optimistic analysts are from companies like Morgan Stanley, Bank of America, and Argus.
Moderna technical analysis
To predict where the stock will end the year, we will look at the weekly chart. On the chart, we see that the stock has been in a bearish trend lately. Along the way, it has moved below the 61.8% Fibonacci retracement level. That is a sign that the stock will likely keep falling in the first part of the year.
Why is Moderna tanking?
As we wrote above, the Moderna stock price forecast is tanking as investors look into the company’s future. They expect that the firm’s business will slow as the hype of vaccinations wane. Worse, the company’s pipeline is still a long way to go to generate returns.
The Rise and Fall of Moderna
Moderna Pipeline
- Another reason why the Moderna stock price has declined is that investors are concerned about the company’s pipeline. A pipeline is the number of vaccines or drugs in various phases of their development. As you can see on this page, the most important vaccines in Moderna’s pipeline are all related to Covid-19. Other vaccines with a long way to go a...
Is Moderna A Good Investment?
- So, the most common question among investors is whether Moderna is a good investment after its stock crashed by more than 60% from its all-time high. There are several reasons to believe that the MRNA stock price will do well in the future. But there are other concerns that the company is a risky one. First, the company has a leading role in fighting Covid-19 and the new va…
Is Moderna Overvalued Or Undervalued?
- So, the most important question that people ask before they invest in a stock is whether it is overvalued or not. So, is the Moderna stock price overvalued? There are various approaches to answering that question. First, let us look at the multiples the stock is trading at. Data compiled by SeekingAlpha shows that Moderna is trading at a trailing PE ratio of 9.77. In contrast, other biote…
Moderna Stock Price Forecast 2022
- Analysts are generally optimistic about the MRNA share price. According to Marketbeat, analysts have an average target of $245 for the stock. That price is about 53% above the current level. The most optimistic analysts are from companies like Morgan Stanley, Bank of America, and Argus. On the other hand, Redburn Partners and Deutsche Bank analysts have a pessimistic view of th…
Moderna Technical Analysis
- To predict where the stock will end the year, we will look at the weekly chart. On the chart, we see that the stock has been in a bearish trend lately. Along the way, it has moved below the 61.8% Fibonacci retracement level. That is a sign that the stock will likely keep falling in the first part of the year. At the same time, we see that the pair is now forming the corrective Elliot wave. While t…
Why Is Moderna Tanking?
- As we wrote above, the Moderna stock price forecast is tanking as investors look into the company’s future. They expect that the firm’s business will slow as the hype of vaccinations wane. Worse, the company’s pipeline is still a long way to go to generate returns. The company will provide an update about these issues when it publishes its results on February 24th.
Summary: Should You Buy moderna?
- Moderna has grown from a small company with no major product to a world leader in Covid vaccines. However, its hype has eased, pushing its stock from almost $500 to $160. Therefore, as mentioned, there is a likelihood that the stock will continue falling for a while and then bounce back in the coming months.